The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2
Open accessAbstract
Patients with biallelic mutations in BRCA2 are in Fanconi anaemia group D1. We analysed the severity of the mutations in 27 cases, classified according to their association with breast cancer in heterozygotes, and their predicted functional effect. Twenty mutations were frameshifts or truncations, three involved splice sites, five were missense variants of unknown severity and two were benign polymorphisms. Five patients had VACTERL-H association. Leukaemia was reported in 13 patients, and solid tumours in 15; 6 patients had two or more malignancies. The cumulative probability of any malignancy was 97% by age 5.2 years. IVS7+1G→A and IVS7+2T→G were associated with AML, and 886delGT and 6174delT with brain tumours. However, patients with other alleles remained at very high risk of these events. Missense mutations formed a distinct cluster in a highly conserved region of the BRCA2 protein. The small group of patients with biallelic mutations in BRCA2 is distinctive in the severity of the phenotype, and early onset and high rates of leukaemia and specific solid tumours, and may comprise an extreme variant of Fanconi anaemia. Several of the alleles were not associated with cancer in presumed carriers, and thus counselling presents more uncertainties than usual.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
Cancer Risks in BRCA2 Mutation Carriers
Breast Cancer Linkage Consortium, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,527
Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198
Biallelic Inactivation of BRCA2 in Fanconi Anemia
Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002) · Science · doi:10.1126/science.1073834 · Cited by 1,149
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D.-S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P., & Bradley, A. (1997) · Nature · doi:10.1038/386804a0 · Cited by 1,072
Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer
Walsh, T., Casadei, S., Coats, K. H., Swisher, E., Stray, S. M., Higgins, J., Roach, K. C., Mandell, J., Lee, M. K., Ciernikova, S., et al. (2006) · JAMA · doi:10.1001/jama.295.12.1379 · Cited by 666
The emerging genetic and molecular basis of Fanconi anaemia
Joenje, H., & Patel, K. J. (2001) · Nature Reviews Genetics · doi:10.1038/35076590 · Cited by 572
Ludwig, T., Chapman, D. L., Papaioannou, V. E., & Efstratiadis, A. (1997) · Genes & Development · doi:10.1101/gad.11.10.1226 · Cited by 539
Cancer incidence in persons with Fanconi anemia
Rosenberg, P. S., Greene, M. H., & Alter, B. P. (2003) · Blood · doi:10.1182/blood-2002-05-1498 · Cited by 520
Self-citationThe Fanconi Anemia/BRCA pathway: new faces in the crowd
Kennedy, R. D., & D'Andrea, A. D. (2005) · Genes & Development · doi:10.1101/gad.1370505 · Cited by 467
The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J
Levitus, M., Waisfisz, Q., Godthelp, B. C., Vries, Y. D., Hussain, S., Wiegant, W. W., Elghalbzouri-Maghrani, E., Steltenpool, J., Rooimans, M. A., Pals, G., et al. (2005) · Nature Genetics · doi:10.1038/ng1625 · Cited by 432
Cancer in Fanconi anemia, 1927–2001
Alter, B. P. (2003) · Cancer · doi:10.1002/cncr.11046 · Cited by 432
Self-citationTumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation
Connor, F., Bertwistle, D., Mee, P. J., Ross, G. M., Swift, S., Grigorieva, E., Tybulewicz, V. L. J., & Ashworth, A. (1997) · Nature Genetics · doi:10.1038/ng1297-423 · Cited by 432
Molecular pathogenesis of Fanconi anemia: recent progress
Taniguchi, T., & D'Andrea, A. D. (2006) · Blood · doi:10.1182/blood-2005-10-4240 · Cited by 393
Nathan and Oski's Hematology of Infancy and Childhood
Nathan, E., & Orkin, S. H. (2002) · Cited by 384
The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia
Levran, O., Attwooll, C., Henry, R. T., Milton, K. L., Neveling, K., Rio, P., Batish, S. D., Kalb, R., Velleuer, E., Barral, S., et al. (2005) · Nature Genetics · doi:10.1038/ng1624 · Cited by 370
X-linked inheritance of Fanconi anemia complementation group B
Meetei, A. R., Levitus, M., Xue, Y., Medhurst, A. L., Zwaan, M., Ling, C., Rooimans, M. A., Bier, P., Hoatlin, M., Pals, G., et al. (2004) · Nature Genetics · doi:10.1038/ng1458 · Cited by 325
Wagner, J. E. (2004) · Blood · doi:10.1182/blood-2003-09-3138 · Cited by 214
Shared Genetic Susceptibility to Breast Cancer, Brain Tumors, and Fanconi Anemia
Offit, K., Levran, O., Mullaney, B., Mah, K., Nafa, K., Batish, S. D., Diotti, R., Schneider, H., Deffenbaugh, A., Scholl, T., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg072 · Cited by 201
Hirsch, B., Shimamura, A., Moreau, L., Baldinger, S., Hag-alshiekh, M., Bostrom, B., Sencer, S., & D'Andrea, A. D. (2004) · Blood · doi:10.1182/blood-2003-06-1970 · Cited by 199
The Breast Cancer Information Core: Database design, structure, and scope
Szabo, C., Masiello, A., Ryan, J. F., The BIC Consortium, & Brody, L. C. (2000) · Human Mutation · doi:10.1002/1098-1004(200008)16:2<123::aid-humu4>3.0.co;2-y · Cited by 193
Self-citationWu, W. K. K., Wong, H. P. S., Luo, S. W., Chan, K., Huang, F. Y., Hui, M. K. C., Lam, E. K. Y., Shin, V. Y., Ye, Y. N., Yang, Y. H., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0205 · Cited by 183
A polymorphic stop codon in BRCA2
Mazoyer, S., Dunning, A. M., Serova, O., Dearden, J., Puget, N., Healey, C. S., Gayther, S. A., Mangion, J., Stratton, M. R., Lynch, H. T., et al. (1996) · Nature Genetics · doi:10.1038/ng1196-253 · Cited by 174
Tumorigenesis in mice carrying a truncating Brca1 mutationPreprint
Ludwig, T. G., Fisher, P. E., Ganesan, S., & Efstratiadis, A. (2001) · Genes & Development · doi:10.1101/gad.879201 · Cited by 130
DEB test for Fanconi anemia detection in patients with atypical phenotypes
Esmer, C., Sánchez, S., Ramos, S., Molina, B., Frı́as, S., & Carnevale, A. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20327 · Cited by 128
Functional Evaluation and Cancer Risk Assessment of BRCA2 Unclassified Variants
Wu, K., Hinson, S. R., Ohashi, A., Farrugia, D. J., Wendt, P., Tavtigian, S. V., Deffenbaugh, A. M., Goldgar, D. E., & Couch, F. J. (2005) · Cancer Research · doi:10.1158/0008-5472.417.65.2 · Cited by 125
Reid, S., Renwick, A., Seal, S., Baskcomb, L., Barfoot, R., Jayatilake, H., Pritchard‐Jones, K., Stratton, M. R., Ridolfi-Lüthy, A., & Rahman, N. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.022673 · Cited by 124
Posey, J., Soloway, M. S., Eki̇ci̇, S., Sofer, M., Civantos, F., DUNCAN, R. C., & Lokeshwar, V. B. (2003) · PubMed · Cited by 117
Godthelp, B. C., Wiegant, W. W., Waisfisz, Q., Medhurst, A. L., Arwert, F., Joenje, H., & Zdzienicka, M. Z. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.07.008 · Cited by 75
Ikeda, H., Matsushita, M., Waisfisz, Q., Kinoshita, A., Oostra, A. B., Nieuwint, A. W. M., de Winter, J. P., Hoatlin, M. E., Kawai, Y., Sasaki, M. S., et al. (2003) · PubMed · Cited by 55
Meyer, S., Fergusson, W. D., Oostra, A. B., Medhurst, A. L., Waisfisz, Q., de Winter, J. P., Chen, F., Carr, T. F., Clayton‐Smith, J., Clancy, T., et al. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20153 · Cited by 28
The BRCA2 genetic variant IVS7 + 2T → G is a mutation
Pyne, M. T., Brothman, A. R., Ward, B., Pruss, D., Hendrickson, B. C., & Scholl, T. (2000) · Journal of Human Genetics · doi:10.1007/s100380070007 · Cited by 23
Brain Tumors in Patients With Fanconi's Anemia
Tenner, M. S. (1994) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1994.02170060115027 · Cited by 22
Inherited Bone Marrow Failure Syndromes
Dror, Y. (2006) · Wiley eBooks · doi:10.1002/9780470987001.ch3 · Cited by 17
The association between FANCD1/BRCA2 mutations and leukaemia
Alter, B. P. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06049.x · Cited by 12
Self-citation
Cited by
DNA interstrand crosslink repair and cancer
Deans, A. J., & West, S. C. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3088 · Cited by 1,023
Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis
Moynahan, M. E., & Jasin, M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2851 · Cited by 930
Chromosome Abnormalities and Genetic Counseling
Gardner, R. J. M., Sutherland, G. R., & Shaffer, L. G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780195375336.001.0001 · Cited by 857
How the Fanconi Anemia Pathway Guards the Genome
Moldovan, G.-L., & D'Andrea, A. D. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134222 · Cited by 590
Pathophysiology and management of inherited bone marrow failure syndromes
Shimamura, A., & Alter, B. P. (2010) · Blood Reviews · doi:10.1016/j.blre.2010.03.002 · Cited by 552
Self-citation
Metadata
- Authors
- Alter, B. P., Rosenberg, P. S., & Brody, L. C.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 2006-07-06
- Volume
- 44
- Issue
- 1
- Pages
- 1-9
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W2124985397
- Cited by
- 341
- References
- 35
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.